Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dienogest alone versus dienogest plus levonorgestrel intrauterine device for endometriosis
RBR-68j3f26Phase 3Not yet recruiting
- Sponsor
- Universidade Estadual de Campinas
- Start
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in endometriosis comparing Dienogest + levonorgestrel intrauterine device with Dienogest alone (2 arms). Planned start Sep 2024; status: not yet recruiting.
02
Drugs
dienogestavatrombopag
03
Conditions
endometriosis
Beyond the preview
Go deeper on RBR-68j3f26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-68j3f26.